Two US com­pa­nies ink deals to ex­pand biosim­i­lar of­fer­ings

In the past week, two com­pa­nies have signed on with Biosim­i­lars So­lu­tions to help the ease of ac­cess and af­ford­abil­i­ty of the drugs.

Ocy­on­Bio and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.